clinical trial · NCT00449111
An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325)
Organon and Co·phase3·terminated·n = 11
HypertensionMK0954, losartan potassium / Duration of Treatment - 12 weeks
brief summary
Evaluate blood pressure after 6 weeks of treatment with COZAAR plus.
started
Mar 13, 2006
primary completion
Sep 30, 2006
completion
Sep 30, 2006
last updated
Aug 15, 2024
official title
An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol